|
|
|
|
|
|
|
05.11.25 - 01:18
|
Clover Health Surges: Profit, Revenue, Membership Up (24/7 Wall St.)
|
|
|
Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.Yet the stock's initial reaction suggested investors remained skeptical about the durability of that turnaround. Revenue climbed to $478.0M, topping estimates of $468.3M, while the company ... Clover Health Surges: Profit, Revenue, Membership Up
The post Clover Health Surges: Profit, Revenue, Membership Up appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
22.10.25 - 22:33
|
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference (GlobeNewswire EN)
|
|
|
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time....
|
|
|
|
|
|
|
|
|
|
|
|
|
07.10.25 - 14:33
|
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire EN)
|
|
|
WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced that it will release its financial results after the market closes on Tuesday, November 4, 2025. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter....
|
|
|
|
|
|
|
|
|
03.09.25 - 20:24
|
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way (GlobeNewswire EN)
|
|
|
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health, positioning Clover as a national leader in AI-enabled healthcare transformation. In his testimony, Andrew highlighted how Clover's proprietary AI platform empowers physicians to deliver more personalized, timely care at the point of service, particularly to seniors in rural and other underserved communities. Motivated by a personal mission to improve care delivery following the loss of his father to complications from uncoordinated care, Andrew shared how Clover uses technology to simplify the healthcare experience and bring smarter, more proactive care to those who need it most....
|
|
|
|